Rehabilitation and repair introduction by Cramer, SC & Nudo, RJ
UC Irvine
UC Irvine Previously Published Works
Title
Rehabilitation and Repair: Introduction
Permalink
https://escholarship.org/uc/item/3t73b39m
Journal
Stroke, 40(3, Supplement 1)
ISSN
0039-2499
Authors
Cramer, SC
Nudo, RJ
Publication Date
2009-03-01
DOI
10.1161/strokeaha.108.533935
License
CC BY 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Rehabilitation
Rehabilitation and Repair
Introduction
Steven C. Cramer, MD; Randolph J. Nudo, PhD
Brain repair after stroke is entering an exciting stage. Thefour articles on this topic that follow examine a number
of the forefronts, including translational efforts, new drug
discovery, brain mapping to measure reorganization in hu-
mans, new national structures for expanding trials in this
setting, the interplay between repair and experience, and the
various therapeutic approaches under investigation.
Dr Larry Goldstein summarizes the many clinical trials
conducted on the effects of d-amphetamine in stroke survi-
vors. This drug has been repeatedly shown to be beneficial in
animal models, especially when combined with behavioral
experience. However, results of clinical trials have been quite
variable, possibly related to differences in dosing regimens,
timing with respect to physiotherapy, or other factors related
to stroke severity. Dr Goldstein emphasizes the critical issues
of trial design in evaluating amphetamine trials in stroke
recovery, including the importance of coupling drug exposure
with the experience of physiotherapy, and concludes that the
effectiveness of this drug remains unanswered.
Dr Theresa Jones and colleagues review the evidence for
the effects of behavioral experience on the anatomy of
dendrites and synapses in the remaining intact cortical tissue
after injury. Dr Jones indicates that these effects can be
adaptive or detrimental, depending on the type and timing of
such experience. Further, behavioral experience, in the form
of increased use of the unimpaired limb after unilateral
damage, produces bihemispheric effects. Combinatorial ther-
apies, such as cortical electric stimulation, may aid the
rehabilitative process by enhancing its effects. Injury, expe-
rience, plasticity, and behavioral outcome have a complex
interrelationship. Further studies might provide a knowledge
base that would allow clinicians to modulate brain plasticity
in a manner that maximizes behavioral gains.
Drs Rajiv Ratan and Mark Noble review the potential for
new therapeutic strategies to improve recovery after brain and
spinal cord injury. They argue that infrastructural support for
more efficient bench-to-bedside translation must be generated
to facilitate the development of novel therapies. It is proposed
that drugs should be developed that target the various
biological epochs that follow stroke, emphasizing stroke
therapeutic targets along a continuum. A strategy of testing
small molecule drugs in high-throughput screening process is
described that has yielded several potential candidates for
therapy. The issues surrounding application of new stroke
therapeutics, such as delivery and route of administration, are
also discussed. A broad perspective of the bench-to-bedside
pathway for producing new stroke repair therapeutics is
considered in this review.
Dr Thomas Kent and colleagues review the evidence for
use-dependent learning after stroke. Analogies exist between
normal learning and brain plasticity after stroke. Evidence
from magnetoencephalography and functional MRI studies
are used to examine how recovery of language function after
stroke resembles a true return of function versus compensa-
tion. Specifically focusing on constraint-induced language
therapy, the authors argue that after stroke, language recovery
is reflective of use-dependent learning, similar to the learning
process that occurs during the acquisition of a foreign
language.
As noted by Drs Ratan and Noble, to date there have been
few trials in humans of therapies that target brain repair after
stroke. Momentum from numerous sources anticipates human
clinical trials, with improved methodology, and with useful
insights from accompanying measures of brain function. The
need for effective restorative therapies is great, as most
patients do not reach medical attention in time to receive
acute stroke therapies, and the majority of those that do still
have significant long-term disability. The pallete of options is
large, from growth factors to cells, brain stimulation to
activity-dependent approaches, and small molecules to
learning-based programs. The future holds great promise for
restorative therapies after stroke.
Disclosures
None.
KEY WORDS: rehabilitation
Received August 5, 2008; accepted August 11, 2008.
From the Departments of Neurology and Anatomy & Neurobiology (S.C.C.), University of California, Irvine; and the Landon Center on Aging and
Department of Molecular and Integrative Physiology (R.J.N.), Kansas University Medical Center, Kansas City, Kans.
Correspondence to Steven Cramer, UCI Medical Center, 101 The City Drive South, Orange, CA 92868-4280. E-mail scramer@uci.edu
(Stroke. 2009;40[suppl 1]:S129.)
© 2009 American Heart Association, Inc.
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.108.533935
S129
